Psallidas, Ioannis <br/><br/>
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.  [electronic resource] 

 -  The Lancet. Oncology  07 2018 
 - 930-939 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(18)30294-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers--blood<br/>Cause of Death<br/>Cohort Studies<br/>Databases, Factual<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pleural Effusion, Malignant--blood<br/>Pleurodesis--methods<br/>Predictive Value of Tests<br/>Prognosis<br/>Reproducibility of Results<br/>Retrospective Studies<br/>Risk Assessment<br/>Severity of Illness Index<br/>Survival Analysis<br/>Treatment Outcome